Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 26, 2025) - A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025.The lawsuit comes after investors saw the price of their shares in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) crash over 60% on May 27, 2025 as a result of the company's announcement...
2025-06-26 9:21 AM EDT
CODI 2-WEEK DEADLINE ALERT: Compass Diversified (CODI) Grapples with Financial Irregularities, Slashes Dividend Amid Investor Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 24, 2025) - Compass Diversified (NYSE: CODI), a Connecticut-based private equity firm, is navigating a turbulent period marked by the recent resignation of a key director, a precipitous stock decline, and a burgeoning class-action lawsuit, all stemming from unearthed accounting irregularities at one of its portfolio companies.Hagens Berman is investigating the claims and urges investors who purchased Compass shares and suffered substantial losses to submit your losses now.Class Period: May 1, 2024 - May...
2025-06-24 1:41 PM EDT
Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 24, 2025) - Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025. Mr. Bellemin, who assumed the CFO role in November 2020, is reportedly departing to pursue other endeavors, according to a regulatory filing. Bellemin's exit comes at a tumultuous time, as the company is grappling with a recent commercial setback for its flagship drug, Amtagvi, and the...
2025-06-24 1:36 PM EDT
NSSC 4-DAY DEADLINE ALERT: Napco (NSSC) Under Scrutiny, Investor Suit and Sales Slump Shake Investor Confidence - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 20, 2025) - Did you suffer substantial losses on your Napco Security Technologies (NASDAQ: NSSC) investments? Hagens Berman reminds investors of a critical deadline: June 24, 2025. This is your deadline for seeking appointment as lead plaintiff in a federal securities class action lawsuit against Napco.If you purchased Napco securities between February 5, 2024, and February 3, 2025, inclusive, and experienced significant losses, click here. You may have legal recourse. Hagens Berman...
2025-06-20 12:23 PM EDT
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 20, 2025) - A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025.The lawsuit comes after investors saw the price of their shares in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) crash over 60% on May 27, 2025 as a result of the company's announcement...
2025-06-20 12:00 PM EDT
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 20, 2025) - Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research-a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.Prominent law...
2025-06-20 11:59 AM EDT
SelectQuote (SLQT) Shares Slide Further on Disappointing Earnings Amidst DOJ Scrutiny- Hagens Berman
San Francisco, California--(Newsfile Corp. - June 19, 2025) - SelectQuote Inc. (NYSE: SLQT) faced renewed investor pressure on Monday, May 12, 2025, as its shares tumbled another 12% following the release of quarterly results that fell short of earnings and revenue expectations. This decline compounds the over 19% drop experienced on May 1st after the U.S. Department of Justice (DOJ) announced a lawsuit alleging violations of the False Claims Act against the insurance brokerage and several major health insurers.Hagens Berman...
2025-06-19 1:07 PM EDT
Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure- Hagens Berman
San Francisco, California--(Newsfile Corp. - June 19, 2025) - Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025. Mr. Bellemin, who assumed the CFO role in November 2020, is reportedly departing to pursue other endeavors, according to a regulatory filing. Bellemin's exit comes at a tumultuous time, as the company is grappling with a recent commercial setback for its flagship drug, Amtagvi, and the...
2025-06-19 1:03 PM EDT
Compass Diversified (CODI) Faces Crisis as Lugano Scandal Forces Downgrade, Investor Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 19, 2025) - Compass Diversified (NYSE: CODI), a Connecticut-based private equity firm, is navigating a turbulent period marked by the recent resignation of a key director, a precipitous stock decline, and a burgeoning class-action lawsuit, all stemming from unearthed accounting irregularities at one of its portfolio companies.Hagens Berman is investigating the claims and urges investors who purchased Compass shares and suffered substantial losses to submit your losses now.Class Period: May 1, 2024 - May...
2025-06-19 1:01 PM EDT
Coinbase Global, Inc. (COIN) Shares Slide Amid Disclosure of Material Cybersecurity Incident - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 19, 2025) - On May 15, 2025, investors in Coinbase Global, Inc. (NASDAQ: COIN) saw the price of their shares slide about 7% after the company announced that it experienced a material cybersecurity incident, raising questions about the adequacy of its internal controls and disclosure processes.Hagens Berman has opened an investigation into possible securities law violations and urges Coinbase investors who suffered substantial losses to submit your losses now. The firm also encourages...
2025-06-19 12:57 PM EDT
Notice to Napco (NSSC) Investors: June 24 Investor Deadline in Napco Securities Class Action- Hagens Berman
San Francisco, California--(Newsfile Corp. - June 17, 2025) - Did you suffer substantial losses on your Napco Security Technologies (NASDAQ: NSSC) investments? Hagens Berman reminds investors of a critical deadline: June 24, 2025. This is your deadline for seeking appointment as lead plaintiff in a federal securities class action lawsuit against Napco.If you purchased Napco securities between February 5, 2024, and February 3, 2025, inclusive, and experienced significant losses, click here. You may have legal recourse. Hagens Berman...
2025-06-17 4:38 PM EDT
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 16, 2025) - A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025.The lawsuit comes after investors saw the price of their shares in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) crash over 60% on May 27, 2025 as a result of the company's announcement...
2025-06-16 2:15 PM EDT
Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 16, 2025) - A year ago, Bay Area biotech firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was riding high on the promise of its newly approved cell therapy, Amtagvi. Today, the mood has shifted dramatically. On May 16, 2025, UBS analysts reportedly slashed their rating on Iovance shares from Buy to Neutral and issued a stark price target cut-from $17 to just $2-citing mounting concerns over the drug's commercial rollout and the company's ability...
2025-06-16 2:00 PM EDT
Compass Diversified (CODI) Faces Crisis as Lugano Scandal Forces Downgrade, Investor Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 16, 2025) - Compass Diversified's (NYSE: CODI) tumultuous spring continued as Jefferies analysts recently downgraded the company's stock amid a sweeping securities class action lawsuit filed by investors, both moves stemming from a widening accounting scandal at its Lugano subsidiary. The dual blows-Wall Street's loss of confidence and mounting legal challenges-have sent Compass's shares into a tailspin, erasing over 70% of the company's market value over the past three months and casting a...
2025-06-16 1:57 PM EDT
NSSC 10-DAY DEADLINE ALERT: Napco (NSSC) Under Scrutiny, Investor Suit and Sales Slump Shake Investor Confidence- Hagens Berman
San Francisco, California--(Newsfile Corp. - June 14, 2025) - Shares in Napco Security Technologies, Inc. (NASDAQ: NSSC) are trading down nearly 21% year-to-date, as the security technology company continues to face heightened scrutiny as it navigates both legal and operational challenges. Most recently, on May 5, 2025, Napco released its third-quarter financial results for fiscal year 2025, revealing mixed performance metrics amid an ongoing securities class action lawsuit that centers on its distribution practices and sales forecasting.Hagens Berman is investigating...
2025-06-14 2:41 PM EDT
UroGen Pharma Ltd. (URGN) Faces Securities Class Action Amid FDA's Briefing Document and Subsequent ODAC Vote Against UGN-102- Hagens Berman
San Francisco, California--(Newsfile Corp. - June 10, 2025) - A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired UroGen securities between July 27, 2023 and May 15, 2025.The lawsuit comes after investors saw the price of their shares in UroGen Pharma Ltd. (NASDAQ: URGN) crash on May 16, 2025 as a result of the FDA's publication of a briefing...
2025-06-10 6:41 PM EDT
Iovance's (IOVA) Promising Cell Therapy Falters Triggering UBS Downgrades and Investor Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 10, 2025) - A year ago, Bay Area biotech firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was riding high on the promise of its newly approved cell therapy, Amtagvi. Today, the mood has shifted dramatically. On May 16, 2025, UBS analysts reportedly slashed their rating on Iovance shares from Buy to Neutral and issued a stark price target cut-from $17 to just $2-citing mounting concerns over the drug's commercial rollout and the company's ability...
2025-06-10 6:35 PM EDT
Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence- Hagens Berman
San Francisco, California--(Newsfile Corp. - June 10, 2025) - Shares in Napco Security Technologies, Inc. (NASDAQ: NSSC) are trading down nearly 21% year-to-date, as the security technology company continues to face heightened scrutiny as it navigates both legal and operational challenges. Most recently, on May 5, 2025, Napco released its third-quarter financial results for fiscal year 2025, revealing mixed performance metrics amid an ongoing securities class action lawsuit that centers on its distribution practices and sales forecasting.Hagens Berman is investigating...
2025-06-10 6:32 PM EDT
Compass Diversified (CODI) Grapples with Financial Irregularities, Slashes Dividend Amid Investor Lawsuit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 10, 2025) - Shares of Compass Diversified (NYSE: CODI) plunged nearly 15 percent in intraday Wednesday trading, as the private equity firm scrambled to shore up its finances following the discovery of troubling accounting practices at one of its subsidiaries, which has sparked a securities class action.Hagens Berman is investigating the claims and urges investors who purchased Compass shares and suffered substantial losses to submit your losses now.Class Period: May 1, 2024 - May...
2025-06-10 6:29 PM EDT
UnitedHealth Group (UNH) Faces New Allegations of Secret Payments to Nursing Homes Amidst Pending Securities Fraud Suit - Hagens Berman
San Francisco, California--(Newsfile Corp. - June 3, 2025) - Shares of UnitedHealth Group (NYSE: UNH), the nation's largest health insurer, fell sharply on May 21, after a British newspaper reported that the company had made undisclosed payments to nursing homes in an effort to reduce hospital transfers, intensifying the scrutiny facing the healthcare conglomerate.The allegations add to UnitedHealth's woes, as the company had to grapple with the filing of a securities fraud class action, the abrupt departure of its CEO,...
2025-06-03 2:15 PM EDT